○Akinari Sugauchi1, Toshihiro Uchihashi1, Kyoko Kurioka1, Seitaro Hio1, Susumu Tanaka1, Tomoki Todo2 (1.Graduate School of Dentistry, Osaka University, 2.The Institute of Medical Science, The University of Tokyo)
Session information
Oral Session
[O13] Oral Session 13"Cancer 2"
Wed. Sep 13, 2023 1:35 PM - 2:55 PM Room 3 (1008, 10F, OICC)
Chairs:Hiroshi Tazawa(Center for Innovative Clinical Medicine, Okayama University Hospital),Tomoyuki Nishikawa()
○Emiko Sonoda Fukuda1, Toru Takarada2, Shunsuke Noguchi3, Noriyuki Kasahara4, Shuji Kubo1 (1.Laboratory of Molecular and Genetic Therapeutics, Advanced Medical Science, Hyogo Medical University, 2.Laboratory of Functional Molecular Chemistry, Kobe Pharmaceutical University, 3.Laboratory of Veterinary Radiology, Graduate School of Veterinary Science, Osaka Metropolitan University, 4.Departments of Neurological Surgery and Radiation Oncology, University of California, San Francisco)
○Hideki Yoshida1, Satoru Oya1, Mitsuru Miyachi1, Shigeki Yagyu1, Yoshiki Katsumi1, Ken Kikuchi1, Kunihiko Tsuchiya1, Eiichi Konishi2, Masato Yamamoto3, Tomoko Iehara1 (1.Department of Pediatrics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan, 2.Department of Surgical Pathology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan, 3.Division of Basic and Translational Research, Department of Surgery, University of Minnesota, MN, USA)
○Hiroaki Inoue1, Hiroshi Tazawa1,2, Yasuo Nagai1, Satoru Kikuchi1, Shinji Kuroda1, Yasuo Urata3, Shunsuke Kagawa1, Toshiyoshi Fujiwara1 (1.Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 2.Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan, 3.Oncolys BioPharma, Inc., Tokyo, Japan)
○Hiroki Niwa1,2, Toru Nakamura1, Hiroki Kushiya1, Tomohiro Suzuki1, Kazuho Inoko1, Kei Hiraoka1,2, Akihito Inagaki3, Takahiro Tsuchikawa1, Toshiaki Shichinohe1, Noriyuki Kasahara3,4, Satoshi Hirano1 (1.Department of Gastroenterological Surgery II, Hokkaido University Graduate School of Medicine, 2.Department of Clinical Research, National Hospital Organization (NHO) Hakodate National Hospital, 3.Departments of Neurological Surgery, University of California, San Francisco (UCSF), 4.Departments of Radiation Oncology, University of California, San Francisco (UCSF))
○Kazuho Inoko1, Margarita Romanenko1, Sacha Robert1, Shuhei Shinoda1, Mizuho Sato-Dahlman1, Kari Jacobsen1, Takuro Noguchi2, Masato Yamamoto1, Julia Davydova1 (1.Division of Basic and Translational Research, Department of Surgery, University of Minnesota, 2.Department of Medical Oncology, Faculty of Medicine, Hokkaido University)
○Miyako Sagara1, Shohei Miyamoto2, Shun Ito1, Yasushi Soda1, Tetsu Akiyama1, Mutsunori Murahashi2, Kenzaburo Tani1 (1.The University of Tokyo, 2.The Jikei University Scool of Medicine)
○Mohamed Abdelmoneim1,2,3, Ibrahim Ragab Eissa1,2,4, Mona Alhussein Aboalela1,2,5, Yoshinori Naoe1, Shigeru Matsumura1, Patricia Sibal1, Itzel Bustos-Villalobos1, Maki Tanaka6, Yasuhiro Kodera2, Hideki Kasuya1 (1.Cancer Immune Therapy Research Center, Graduate School of Medicine, Nagoya University, Nagoya, Japan, 2.Department of Surgery II, Graduate School of Medicine, Nagoya University, Japan, 3.Department of Microbiology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt, 4.Faculty of Science, Tanta University, Tanta, Egypt, 5.Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University, Zagazig. Egypt., 6.Takara Bio Inc., Kusatsu, Shiga, Japan)